Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Colglazier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Pulmonary Circulation|May 4, 2022
Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closerLeah Stevens, Elizabeth Colglazier, Claire Parker, et al.
Pulmonary Circulation|September 21, 2023
Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case seriesElizabeth Colglazier, Angelica J Ng, Claire Parker, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2024
MicroRNA in pediatric pulmonary hypertension microRNA profiling to inform disease classification, severity, and treatment response in pediatric pulmonary hypertensionMichael A Smith, Sam Chiacchia, Jason Boehme, et al.
Pulmonary Circulation|April 15, 2024
A single institution anesthetic experience with catheterization of pediatric pulmonary hypertension patientsEmily Morell, Elizabeth Colglazier, Jasmine Becerra, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 4, 2025
Detailed Autopsies Performed on Two Females With Myhre Syndrome Elucidate Features of SMAD4 Gain-of-Function PathophysiologyKatelyn Dannheim, Grant Eilers, Nathan C Page, et al.
Pulmonary Circulation|May 5, 2023
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patientsJulia McSweeney, Elizabeth Colglazier, Jasmine Becerra, et al.
Journal of Medical Genetics|September 8, 2021
Biallelic variants of <i>ATP13A3</i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortalityRajiv D Machado, Carrie L Welch, Matthias Haimel, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Pulmonary Circulation|May 4, 2022
Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closerLeah Stevens, Elizabeth Colglazier, Claire Parker, et al.
Pulmonary Circulation|September 21, 2023
Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case seriesElizabeth Colglazier, Angelica J Ng, Claire Parker, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2024
MicroRNA in pediatric pulmonary hypertension microRNA profiling to inform disease classification, severity, and treatment response in pediatric pulmonary hypertensionMichael A Smith, Sam Chiacchia, Jason Boehme, et al.
Pulmonary Circulation|April 15, 2024
A single institution anesthetic experience with catheterization of pediatric pulmonary hypertension patientsEmily Morell, Elizabeth Colglazier, Jasmine Becerra, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 4, 2025
Detailed Autopsies Performed on Two Females With Myhre Syndrome Elucidate Features of SMAD4 Gain-of-Function PathophysiologyKatelyn Dannheim, Grant Eilers, Nathan C Page, et al.
Pulmonary Circulation|May 5, 2023
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patientsJulia McSweeney, Elizabeth Colglazier, Jasmine Becerra, et al.
Journal of Medical Genetics|September 8, 2021
Biallelic variants of <i>ATP13A3</i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortalityRajiv D Machado, Carrie L Welch, Matthias Haimel, et al.
Pageof 2